Results 81 to 90 of about 9,117 (217)
Association between copy number variation of complement component C4 and Graves' disease [PDF]
Background Gene copy number of complement component C4, which varies among individuals, may determine the intrinsic strength of the classical complement pathway.
Yu-Huei Liu +7 more
core +2 more sources
ABSTRACT Purpose Dysthyroid Optic Neuropathy (DON) is a sight threatening and diagnostically challenging complication of Thyroid Eye Disease (TED). We provide a comparative analysis of the MRI features associated between patietnts with and without DON. Methods Anonymised retrospective cohort study of patients with TED over eleven years.
Malik Moledina +11 more
wiley +1 more source
Revolutionizing Autoimmune Research: The Role of Caveolin‐1
ABSTRACT Introduction Caveolins (Cav) include Cav‐1, Cav‐2, and Cav‐3, with Cav‐1 being the most studied due to its prominent role as a major component of plasma membrane caveolae. Cav‐1 is involved in a wide range of cellular functions and plays a key role in regulating signaling pathways related to immune responses and inflammation.
Yanan Gao +8 more
wiley +1 more source
ABSTRACT Autoimmune disorders occur when the body's immune system mistakenly attacks its own tissues. Generally, these disorders are more prevalent in female patients. The presence of one autoimmune disease can alter the immune system's balance, making the individual more susceptible to developing other autoimmune conditions.
Suaad Hamsho +2 more
wiley +1 more source
Age Influences the Severity of Graves' Ophthalmopathy
This study compared the ocular manifestations of Graves' disease in different age groups and between genders. This was a retrospective study with a chart review of 210 patients seen in the Kaohsiung Veterans General Hospital Ophthalmology Department from
Muh-Chiou Lin +3 more
doaj +1 more source
Active Moderate-to-Severe Graves' Orbitopathy in a Patient With Type 2 Diabetes Mellitus and Vascular Complications [PDF]
Background: Graves’ orbitopathy (GO) is the main extrathyroidal manifestation of Graves’ disease (GD). Diabetes mellitus (DM) has been reported to be a risk factor in patients with GO.
Biondi, B +5 more
core +2 more sources
Jack R Wall,1 Hooshang Lahooti,1 Ilhem El Kochairi,1 Simon D Lytton,2 Bernard Champion1 1Department of Medicine, the University of Sydney, Penrith, NSW, Australia; 2SeraDiaLogistics, Munich, Germany Abstract: Although ophthalmopathy is mainly ...
Wall JR +4 more
doaj
Color Doppler imaging of the superior ophthalmic vein in patients with Graves' orbitopathy before and after treatment of congestive disease [PDF]
OBJECTIVE: To compare superior ophthalmic vein blood flow parameters measured with color Doppler imaging in patients with congestive Graves' orbitopathy before and after treatment and in normal controls.
ANGOTTI NETO, Hélio +3 more
core +5 more sources
Clinical Presentation of Graves’ Ophthalmopathy
The eye findings of Graves' ophthalmopathy were prospectively recorded in 90 consecutive untreated patients (66 females, 24 males; mean age 44.5 years) according to the 1977 NOSPECS classification. Soft-tissue involvement was observed in 90%, proptosis greater than or equal to 23 mm in 30%, eye muscle involvement in 60%, corneal involvement in 9% and ...
Wiersinga, W. M. +4 more
openaire +3 more sources
Association between G protein polymorphisms (GNAS1 T393C and GNB3 C825T) and course of Graves’ disease and Graves’ orbitopathy [PDF]
Summary The biology of initiation and progression of Graves’ hyperthyroidism and Graves’ orbitopathy is complex. For the individually tailored therapy of the diseases it is very important to identify the risk factors.
Dmuchowska, Diana
core

